A new analysis says allowing beneficiaries in Medicare Part D to benefit from drug manufacturer rebates shows that they could save $29 billion. But if another proposal is chosen, they would save less, and taxpayer costs would rise.
A small 5-year all-cause mortality risk increase among patients with chronic obstructive pulmonary disease (COPD) using roflumilast was found in Germany and the US.
While psychedelics like LSD and psilocybin are generally well tolerated in clinical and research settings, study authors suspect inconsistent reporting of adverse events.
The trend of food insecurity continued in 2023, according to a report from the Department of Agriculture.
Dr. Rugo details her management strategy in regards to GI toxicities.
Discussions of social determinants of health might focus on the obvious ones—like income or education—while overlooking some other social determinants that impact health in complex…
After a brief introduction, medical experts discuss advances in MDS classification and molecular understanding.
Medical experts discuss the data gathered from the ASCERTAIN trial.
Attendees of the first Institute for Value-Based Medicine® regional event will hear top experts from Boston-area institutions speak about treating non–small cell lung cancer, targeting…
Jason Porter, MD, analyzes the TROPION-Lung05 trial investigating Dato-DXd in non-small cell lung cancer patients with brain metastases, emphasizing crucial insights from this pivotal study.
New findings add to the relationship between red meat and processed meat consumption and the risk of type 2 diabetes.
